April 17, 2018
Sanofi sells Zentiva for €1.9 billion
Sanofi has gotten an offer from Advent International, a global investor in healthcare sector, for purchase of Zentiva, Sanofi’s European…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Sanofi
April 12, 2018
Sanofi investing €350 million for new vaccine factory in Canada
Sanofi is investing €350 million for the construction of a new vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters…
March 29, 2018
EMA to review Sanofi’s potential treatment for type 1 diabetes
The European Medicines Agency (EMA) has accepted for review Sanofi’s regulatory submission for oral treatment sotagliflozin, developed in partnership with…
March 8, 2018
Sanofi, Evotec to accelerate infectious disease R&D with new open innovation platform
Evotec and Sanofi have entered exclusive talks to create an Evotec-led Infectious Disease open innovation R&D platform, the companies said…
February 23, 2018
Sanofi in closure of $11.6 billion hemophilia specialist buy
Sanofi’s waiting period to complete the purchase of Bioverativ has came to an end, and will thus expand its hemophilia and other…
January 31, 2018
Sanofi asks EMA to review drug for sleeping sickness
Sanofi has asked the European Medicines Agency (EMA) to review fexinidazole for the treatment of sleeping sickness. Fexinidazole is being…
January 29, 2018
Sanofi buys Ablynx for €3,9 billion
Sanofi will buy Belgian Nanobody technology specialist Ablynx for €3.9 billion, it was announced Monday by both companies.
January 22, 2018
Sanofi goes shopping, buys Bioverativ, for $11.6 billion, adds hemophilia and other rare blood disorders specialist to the basket
Sanofi will buy Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, for $11,6…
January 19, 2018
STADA to early terminate license agreement with Sanofi for head lice lotion Hedrin
STADA Arzneimittel AG is advancing the internationalization of its OTC brand business. On January 12, 2018, the company reached an…
January 8, 2018
Sanofi and Regeneron to boost investment for two development programs
Sanofi and Regeneron Pharmaceuticals said they will accelerate and expand investment for the clinical development of the PD-1 (programmed cell…